![Diabetes - Wsimg.com](http://s1.studyres.com/store/data/022422585_1-b5ce2bd35dccb386a6893a786dbfed58-300x300.png)
Diabetes - Wsimg.com
... 40mmol K added to each bag, strict fluid balanceNG tubes and catheter with fluid balance chart and check electrolytes and glucose every hour • Insulin-0.1U/Kg intravenous insulin infusion, aim to reduce glucose by 3mmol/L per hour (fasterrisk of cerebral oedema) • Introduce 10% glucose when BMs <14 ...
... 40mmol K added to each bag, strict fluid balanceNG tubes and catheter with fluid balance chart and check electrolytes and glucose every hour • Insulin-0.1U/Kg intravenous insulin infusion, aim to reduce glucose by 3mmol/L per hour (fasterrisk of cerebral oedema) • Introduce 10% glucose when BMs <14 ...
Endocrine System - Mercer Island School District
... Both Glucagon and Insulin help to regulate sugar in the bloodstream If there is not enough sugar in the bloodstream, Glucagon will add more sugar to the bloodstream and Insulin will make sure there is not too much released If there is too much sugar in the bloodstream, Insulin will store more sugar ...
... Both Glucagon and Insulin help to regulate sugar in the bloodstream If there is not enough sugar in the bloodstream, Glucagon will add more sugar to the bloodstream and Insulin will make sure there is not too much released If there is too much sugar in the bloodstream, Insulin will store more sugar ...
Algorithm for the Treatment and Management of
... •Check for signs of lipohypertrophy (lumpy areas at injection sites) which may affect insulin absorption •Check credibility of blood glucose monitoring e.g. handwashing before testing ...
... •Check for signs of lipohypertrophy (lumpy areas at injection sites) which may affect insulin absorption •Check credibility of blood glucose monitoring e.g. handwashing before testing ...
Management
... True medical emergency resulting from low blood glucose levels; rarely seen outside diabetics. By the time signs and symptoms develop, most of the body’s stores have been used. Diabetics with kidney failure are predisposed to hypoglycemia. ...
... True medical emergency resulting from low blood glucose levels; rarely seen outside diabetics. By the time signs and symptoms develop, most of the body’s stores have been used. Diabetics with kidney failure are predisposed to hypoglycemia. ...
Palliative care and diabetes
... Key imperatives: Important to control hyperglycaemia If patient losing weight may need to stop Metformin, (?temporarily) and SU used instead or insulin May need calorie dense foods to maintain nutrition and weight – diabetes medication to cover Patients must be able to monitor blood glucose but 1 -2 ...
... Key imperatives: Important to control hyperglycaemia If patient losing weight may need to stop Metformin, (?temporarily) and SU used instead or insulin May need calorie dense foods to maintain nutrition and weight – diabetes medication to cover Patients must be able to monitor blood glucose but 1 -2 ...
Diabetic Ketoacidosis
... Continue #4 until glucose is < 250 and the fluid below can be started. Start 1000 mL D5-1/2 NS with 10 mEq KCl at 250mL/hr when glucose < 250 mg per dL. Protocol for intravenous insulin infusion TA B L E 1 General guidelines • Goal blood glucose level = 100-140 (usually 80–180 mg/dL, 80–110 for inte ...
... Continue #4 until glucose is < 250 and the fluid below can be started. Start 1000 mL D5-1/2 NS with 10 mEq KCl at 250mL/hr when glucose < 250 mg per dL. Protocol for intravenous insulin infusion TA B L E 1 General guidelines • Goal blood glucose level = 100-140 (usually 80–180 mg/dL, 80–110 for inte ...
Ketosis prone Diabetes Mellitus type 2
... Diabetes is these patients is characterised by an acute presentation, an autosomal dominant pattern of inheritance, negative islet-cell antibodies, and an insulin response to mixed meals that was intermediate between that seen in non-diabetic controls and in patients with type 1 diabetes. Studies ha ...
... Diabetes is these patients is characterised by an acute presentation, an autosomal dominant pattern of inheritance, negative islet-cell antibodies, and an insulin response to mixed meals that was intermediate between that seen in non-diabetic controls and in patients with type 1 diabetes. Studies ha ...
diabetes_with_ketoacidosis
... blood flow to the tissues and to maintain blood volume; also helps to reduce blood glucose concentration ...
... blood flow to the tissues and to maintain blood volume; also helps to reduce blood glucose concentration ...
Hypoglycaemia_protocol_April_2012
... Treat hypoglycaemia as per protocol. Observe patient until recovery complete and provide information on hypoglycaemia management. Consult diabetes team for advice if necessary. • Establish the cause of hypoglycaemia and take action to prevent recurrence. Inform patient if medication dose is changed ...
... Treat hypoglycaemia as per protocol. Observe patient until recovery complete and provide information on hypoglycaemia management. Consult diabetes team for advice if necessary. • Establish the cause of hypoglycaemia and take action to prevent recurrence. Inform patient if medication dose is changed ...
Protocol for treatment of hypoglycaemia
... Treat hypoglycaemia as per protocol. Observe patient until recovery complete and provide information on hypoglycaemia management . Consult diabetes team for advice if necessary. • Establish the cause of hypoglycaemia and take action to prevent recurrence. Inform patient if medication dose is changed ...
... Treat hypoglycaemia as per protocol. Observe patient until recovery complete and provide information on hypoglycaemia management . Consult diabetes team for advice if necessary. • Establish the cause of hypoglycaemia and take action to prevent recurrence. Inform patient if medication dose is changed ...
Document
... Treat hypoglycaemia as per protocol. Observe patient until recovery complete and provide information on hypoglycaemia management . Consult diabetes team for advice if necessary. • Establish the cause of hypoglycaemia and take action to prevent recurrence. Inform patient if medication dose is changed ...
... Treat hypoglycaemia as per protocol. Observe patient until recovery complete and provide information on hypoglycaemia management . Consult diabetes team for advice if necessary. • Establish the cause of hypoglycaemia and take action to prevent recurrence. Inform patient if medication dose is changed ...
Endocrine System
... 5. Increase activity of the adrenal cortex can result in __________________ - obesity, increase blood sugar levels, high blood pressure, and weakening of bones. 6. "Fight or flight" hormones - nerve impulses from the sympathetic nervous system results in the secretion of _____________ and __________ ...
... 5. Increase activity of the adrenal cortex can result in __________________ - obesity, increase blood sugar levels, high blood pressure, and weakening of bones. 6. "Fight or flight" hormones - nerve impulses from the sympathetic nervous system results in the secretion of _____________ and __________ ...
Hyperosmotic Hyperglycaemic Non-Ketotic
... (6) Fluid management in second 24 hours - when glucose < 15mmol/L -> use D5W @ 100-250mL/hr AND saline - keep Na+ between 140-150mmol/L - the metabolic acidosis rarely requires specific treatment as responds to volume expansion and insulin therapy. ...
... (6) Fluid management in second 24 hours - when glucose < 15mmol/L -> use D5W @ 100-250mL/hr AND saline - keep Na+ between 140-150mmol/L - the metabolic acidosis rarely requires specific treatment as responds to volume expansion and insulin therapy. ...
An introduction to diabetes
... Type 1 Develops when there is a severe lack of insulin in the body because most or all insulin producing beta cells in the pancreas have been destroyed. This is treated by insulin injections and diet Type 2 Develops when pancreas still produces insulin but there is cellular resistance and insuli ...
... Type 1 Develops when there is a severe lack of insulin in the body because most or all insulin producing beta cells in the pancreas have been destroyed. This is treated by insulin injections and diet Type 2 Develops when pancreas still produces insulin but there is cellular resistance and insuli ...
Laboratory Values
... Clinicians need to identify and classify systemic disorders and appropriately modify diagnosis and treatment planning in order to avoid systemic complications. Diagnosis is based on: previous history, medication lists, symptoms, clinical signs, clinical tests such as radiographs and laboratory data. ...
... Clinicians need to identify and classify systemic disorders and appropriately modify diagnosis and treatment planning in order to avoid systemic complications. Diagnosis is based on: previous history, medication lists, symptoms, clinical signs, clinical tests such as radiographs and laboratory data. ...
Feline Diabetes - Lodi Veterinary Care
... What follow-up is involved with treating diabetes in cats? In the non-diabetic cat, adequate amounts of insulin are produced continually (or as needed) by the pancreas to maintain normal blood sugar levels. When we give insulin injections, we administer a fixed amount at one time and that insulin i ...
... What follow-up is involved with treating diabetes in cats? In the non-diabetic cat, adequate amounts of insulin are produced continually (or as needed) by the pancreas to maintain normal blood sugar levels. When we give insulin injections, we administer a fixed amount at one time and that insulin i ...
Diabetes in older adults
... Fifteen percent of patients over 65 years have diabetes and approximately 20-30% of nursing home residents. More than 50% of diabetics are over 65 years. Diabetes may lead to admission at a younger age to long-term care facilities, secondary to visual loss or amputations. ...
... Fifteen percent of patients over 65 years have diabetes and approximately 20-30% of nursing home residents. More than 50% of diabetics are over 65 years. Diabetes may lead to admission at a younger age to long-term care facilities, secondary to visual loss or amputations. ...
endocrine2organs2013 30KB
... Endocrine: Islet cell secretions: produced by Islets of Langerhans in the pancreas. Pancreas makes insulin and glucagon (pg ref bartsch 26-27, 10-11, and aud 657): hormones work in tandem to regulate cellular uptake of glucose: Insulin decreases blood sugar in response to high blood sugar levels G ...
... Endocrine: Islet cell secretions: produced by Islets of Langerhans in the pancreas. Pancreas makes insulin and glucagon (pg ref bartsch 26-27, 10-11, and aud 657): hormones work in tandem to regulate cellular uptake of glucose: Insulin decreases blood sugar in response to high blood sugar levels G ...
How do diets that limit your carbohydrate consumption cause weight
... sugar as fuel. To turn sugars into fuel, your body uses the hormone insulin. Insulin enables our cells to turn carbohydrates into glucose by controlling the amount of sugar in our blood. The body secretes insulin to keep blood sugar from getting too high. Insulin is a storage hormone, meaning that i ...
... sugar as fuel. To turn sugars into fuel, your body uses the hormone insulin. Insulin enables our cells to turn carbohydrates into glucose by controlling the amount of sugar in our blood. The body secretes insulin to keep blood sugar from getting too high. Insulin is a storage hormone, meaning that i ...
diabetes with ketoacidosis
... Medications presented in this section are intended to provide general information about possible treatment. The treatment for a particular condition may evolve as medical advances are made; therefore, the medications should not be considered as all inclusive. Insulin Regular insulin is the insulin ...
... Medications presented in this section are intended to provide general information about possible treatment. The treatment for a particular condition may evolve as medical advances are made; therefore, the medications should not be considered as all inclusive. Insulin Regular insulin is the insulin ...
Diabetes-case-study-2.doc
... 75/25 and 50/50 Humalog O: 0-15 min D; 15-18 hours 70/30 and 50/50 O: 30 min D: 12 hours 70/30 Novolog O: 10-20 min D: 15-18 hours 5. Identify patients requiring referral to a Diabetic Specialty group. (5 points) A patient requiring a diabetic specialty group would be one that cannot maintain adequa ...
... 75/25 and 50/50 Humalog O: 0-15 min D; 15-18 hours 70/30 and 50/50 O: 30 min D: 12 hours 70/30 Novolog O: 10-20 min D: 15-18 hours 5. Identify patients requiring referral to a Diabetic Specialty group. (5 points) A patient requiring a diabetic specialty group would be one that cannot maintain adequa ...
Home Blood Glucose Testing Patient Information Leaflet
... When you have diabetes, it is important to manage your blood glucose level both to help you feel your best and prevent long-term complications. Monitoring your blood glucose levels yourself with a blood glucose meter is an effective way to help you manage your diabetes. It is not necessary for all p ...
... When you have diabetes, it is important to manage your blood glucose level both to help you feel your best and prevent long-term complications. Monitoring your blood glucose levels yourself with a blood glucose meter is an effective way to help you manage your diabetes. It is not necessary for all p ...
Artificial pancreas
The artificial pancreas is a technology in development to help people with diabetes automatically control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.There are several important exocrine (digestive) and endocrine (hormonal) functions of the pancreas, but it is the lack of insulin production which is the motivation to develop a substitute. While the current state of insulin replacement therapy is appreciated for its life-saving capability, the task of manually managing the blood sugar level with insulin alone is arduous and inadequate.The goal of the artificial pancreas is two-fold:to improve insulin replacement therapy until glycemic control is practically normal as evident by the avoidance of the complications of hyperglycemia, and to ease the burden of therapy for the insulin-dependent.Different approaches under consideration include: the medical equipment approach—using an insulin pump under closed loop control using real-time data from a continuous blood glucose sensor. the bioengineering approach—the development of a bio-artificial pancreas consisting of a biocompatible sheet of encapsulated beta cells. When surgically implanted, the islet sheet will behave as the endocrine pancreas and will be viable for years. the gene therapy approach—the therapeutic infection of a diabetic person by a genetically engineered virus which causes a DNA change of intestinal cells to become insulin-producing cells.